Personal Genomics Firm 23andMe Patents Designer Baby System
An anonymous reader writes "Consumer genomics company 23andMe has developed a system for helping prospective parents choose the traits of their offspring, from disease risk to hair color. The patent — number 8543339, "Gamete donor selection based on genetic calculations" — describes a technology that would take a customer's preferences for a child's traits, compute the likely genomic outcomes of combinations between a customer's sperm or egg and other people's sex cells, and describe which potential reproductive matches would most likely produce the desired baby."
Hmm, sounds like the logical next step is a dating service to match those traits. Who's doing the cyber-squatting for 23harmony.com and eugenicsmingle.com?
Ok, if Monsanto can sue a farmer for reusing a genetically modified seed, does this mean that Personal Genomics could sue the kids when they give you grand kids?
I imagine most readers are worried about super-strength people, but on a more practical basis, this could be used to prevent genetic predisposition to disease, like breast cancer gene carriers being able to ensure their child won't be carriers of the gene, or even the mentally ill from passing on genes related to say, schizophrenia.
It COULD be used to screen for undesirable traits (but that's eugenics), it WILL be used to screen for 'desirable' traits - that's money.
Faster! Faster! Faster would be better!
Ah, but the question is do these guys actually have a specific implementation?
Or is this a business process patent disguised as a specific implementation?
I don't know enough about the state of genetics to know if they can do this or not. But so many patents are just bafflegab intended to make it look like you've solved a problem -- when in fact you've just enumerated some of the things you'd need and don't have a way of doing it.
The devil is in the details, and I'm skeptical they have anything more than a series of whitepapers detailing how you'd go about it.
Lost at C:>. Found at C.